Skip to content
healthcare.dev

HepaGam B

NDC 49591-052, HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN, injection, solution, from Kamada Ltd..

Product NDC
49591-052
Status
Listed
Labeler
Kamada Ltd.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125035
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49591-052 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN312 [iU]/mL

Pharmacologic classes

Human Immunoglobulin [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]; Virus Neutralization [MoA]; Virus-specific Hyperimmune Globulins [EXT]

Package NDCNDC-11Package
49591-052-51495910052511 VIAL, GLASS in 1 CARTON (49591-052-51) / 1 mL in 1 VIAL, GLASS (49591-052-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=49591-052

Use it

Look up 49591-052 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49591-052 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49591-052. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.